Back to Network
3
Shared Docs
3
Same-Page
3 / 3
Mentions
Document Mentions (3 shared documents)
2 mentions1 same-page
Page ?Same page
, he was a private consultant from 2006 to 2007. Prior to that he served as President and CEO of Chiron Corporation from 2003 to its acquisition by Novartis AG in 2006. Prior to that he served in various executive capacities for GlaxoSmithKline plc (GSK) and its predecessor companies, culminating in his te
regulatory and medical affairs activities associated with Cell Genesys' product portfolio. Prior to Cell Genesys, he was Chief Executive Officer of Biolitec Pharma Ltd., a U.K.-based biotechnology company, and also previously held senior executive positions with Quantanova and Scotia Holdings, plc. Prior to that, D
2 mentions1 same-page
Page ?Same page
, he was a private consultant from 2006 to 2007. Prior to that he served as President and CEO of Chiron Corporation from 2003 to its acquisition by Novartis AG in 2006. Prior to that he served in various executive capacities for GlaxoSmithKline plc (GSK) and its predecessor companies, culminating in his te
regulatory and medical affairs activities associated with Cell Genesys' product portfolio. Prior to Cell Genesys, he was Chief Executive Officer of Biolitec Pharma Ltd., a U.K.-based biotechnology company, and also previously held senior executive positions with Quantanova and Scotia Holdings, plc. Prior to that, D
2 mentions1 same-page
Page ?Same page
, he was a private consultant from 2006 to 2007. Prior to that he served as President and CEO of Chiron Corporation from 2003 to its acquisition by Novartis AG in 2006. Prior to that he served in various executive capacities for GlaxoSmithKline plc (GSK) and its predecessor companies, culminating in his te
regulatory and medical affairs activities associated with Cell Genesys' product portfolio. Prior to Cell Genesys, he was Chief Executive Officer of Biolitec Pharma Ltd., a U.K.-based biotechnology company, and also previously held senior executive positions with Quantanova and Scotia Holdings, plc. Prior to that, D
Sponsored
Mutual Connections (64)
Entities connected to both Novartis AG and Biolitec Pharma Ltd.
Alan Dershowitz
PERSON8 w/ Novartis·3 w/ Biolitec
Basel
ORGANIZATION7 w/ Novartis·3 w/ Biolitec
Merck
ORGANIZATION7 w/ Novartis·3 w/ Biolitec
the Board of Directors
ORGANIZATION4 w/ Novartis·3 w/ Biolitec
Silicon Valley
LOCATION3 w/ Novartis·3 w/ Biolitec
Merck & Co.
ORGANIZATION3 w/ Novartis·3 w/ Biolitec
Kansas
LOCATION3 w/ Novartis·3 w/ Biolitec
Target
ORGANIZATION3 w/ Novartis·3 w/ Biolitec
Elkins
PERSON3 w/ Novartis·3 w/ Biolitec
Investigatorship
ORGANIZATION3 w/ Novartis·3 w/ Biolitec
Biosecurity
ORGANIZATION3 w/ Novartis·3 w/ Biolitec
Strategic Product Development
ORGANIZATION3 w/ Novartis·3 w/ Biolitec
Cell Genesys'
ORGANIZATION3 w/ Novartis·3 w/ Biolitec
Quantanova
ORGANIZATION3 w/ Novartis·3 w/ Biolitec
the University of St. Andrews
ORGANIZATION3 w/ Novartis·3 w/ Biolitec
the Faculty of Pharmaceutical Physicians
ORGANIZATION3 w/ Novartis·3 w/ Biolitec
Cobalt Technologies, Inc.
ORGANIZATION3 w/ Novartis·3 w/ Biolitec
Xenogen Corporation
ORGANIZATION3 w/ Novartis·3 w/ Biolitec
Microbiology and Engineering
ORGANIZATION3 w/ Novartis·3 w/ Biolitec
Medarex, Inc.
ORGANIZATION3 w/ Novartis·3 w/ Biolitec